Screener
Aldeyra Therapeutics ALDX Q2 2026 earnings
Reported August 6, 2026 · Before market open
EPS-$0.09Miss by $0.00
Revenue estimate$31.3M
EPS estimate-$0.09
Next report
Nov 4, 2026 (in 2 months)Revenue estimate$2.5M
EPS estimate-$0.11
Versus estimates
Diluted EPS
FAQ
- When did Aldeyra Therapeutics report Q2 2026 earnings?
- Aldeyra Therapeutics (ALDX) reported Q2 2026 earnings on August 6, 2026 before market open.
- What were Aldeyra Therapeutics's Q2 2026 revenue and EPS?
- Aldeyra Therapeutics reported eps of $-0.09 for Q2 2026.
- Did Aldeyra Therapeutics beat estimates in Q2 2026?
- EPS missed the consensus estimate of $-0.09 by $0.00.
- How did Aldeyra Therapeutics's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 43.8% from $-0.16.
- Where can I find Aldeyra Therapeutics's Q2 2026 SEC filings?
- You can read the 10-Q periodic report (0001341235-26-000010) directly on SEC EDGAR. The filing index links above go to sec.gov.
